257 related articles for article (PubMed ID: 26616858)
1. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.
O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS
Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858
[TBL] [Abstract][Full Text] [Related]
2. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.
Muppidi JR; Schmitz R; Green JA; Xiao W; Larsen AB; Braun SE; An J; Xu Y; Rosenwald A; Ott G; Gascoyne RD; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Vaidehi N; Staudt LM; Cyster JG
Nature; 2014 Dec; 516(7530):254-8. PubMed ID: 25274307
[TBL] [Abstract][Full Text] [Related]
3. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
Teo CR; Casey PJ; Rasheed SA
Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
[TBL] [Abstract][Full Text] [Related]
4. A Blk-p190RhoGAP signaling module downstream of activated Gα13 functionally opposes CXCL12-stimulated RhoA activation and cell invasion.
Bartolomé RA; Díaz-Martínez M; Coló GP; Arellano-Sánchez N; Torres-Ayuso P; Kleinovink JW; Mérida I; Teixidó J
Cell Signal; 2014 Nov; 26(11):2551-61. PubMed ID: 25025568
[TBL] [Abstract][Full Text] [Related]
5. Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration.
Scarlett KA; White EZ; Coke CJ; Carter JR; Bryant LK; Hinton CV
Mol Cancer Res; 2018 Apr; 16(4):728-739. PubMed ID: 29330286
[TBL] [Abstract][Full Text] [Related]
6. The interaction of Gα13 with integrin β1 mediates cell migration by dynamic regulation of RhoA.
Shen B; Estevez B; Xu Z; Kreutz B; Karginov A; Bai Y; Qian F; Norifumi U; Mosher D; Du X
Mol Biol Cell; 2015 Oct; 26(20):3658-70. PubMed ID: 26310447
[TBL] [Abstract][Full Text] [Related]
7. The genetic landscape of mutations in Burkitt lymphoma.
Love C; Sun Z; Jima D; Li G; Zhang J; Miles R; Richards KL; Dunphy CH; Choi WW; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers CR; Naresh KN; Evens AM; Chadburn A; Gordon LI; Czader MB; Gill JI; Hsi ED; Greenough A; Moffitt AB; McKinney M; Banerjee A; Grubor V; Levy S; Dunson DB; Dave SS
Nat Genet; 2012 Dec; 44(12):1321-5. PubMed ID: 23143597
[TBL] [Abstract][Full Text] [Related]
8. GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.
Rasheed SAK; Leong HS; Lakshmanan M; Raju A; Dadlani D; Chong FT; Shannon NB; Rajarethinam R; Skanthakumar T; Tan EY; Hwang JSG; Lim KH; Tan DS; Ceppi P; Wang M; Tergaonkar V; Casey PJ; Iyer NG
Oncogene; 2018 Mar; 37(10):1340-1353. PubMed ID: 29255247
[TBL] [Abstract][Full Text] [Related]
9. The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling.
Flori M; Schmid CA; Sumrall ET; Tzankov A; Law CW; Robinson MD; Müller A
Blood; 2016 Mar; 127(11):1438-48. PubMed ID: 26729899
[TBL] [Abstract][Full Text] [Related]
10. Naturally occurring hotspot cancer mutations in Gα
Maziarz M; Federico A; Zhao J; Dujmusic L; Zhao Z; Monti S; Varelas X; Garcia-Marcos M
J Biol Chem; 2020 Dec; 295(49):16897-16904. PubMed ID: 33109615
[TBL] [Abstract][Full Text] [Related]
11. RhoA- and RhoD-dependent regulatory switch of Galpha subunit signaling by PAR-1 receptors in cellular invasion.
Nguyen QD; Faivre S; Bruyneel E; Rivat C; Seto M; Endo T; Mareel M; Emami S; Gespach C
FASEB J; 2002 Apr; 16(6):565-76. PubMed ID: 11919159
[TBL] [Abstract][Full Text] [Related]
12. G2A is an oncogenic G protein-coupled receptor.
Zohn IE; Klinger M; Karp X; Kirk H; Symons M; Chrzanowska-Wodnicka M; Der CJ; Kay RJ
Oncogene; 2000 Aug; 19(34):3866-77. PubMed ID: 10951580
[TBL] [Abstract][Full Text] [Related]
13. Gα12/13 signaling promotes cervical cancer invasion through the RhoA/ROCK-JNK signaling axis.
Yuan B; Cui J; Wang W; Deng K
Biochem Biophys Res Commun; 2016 May; 473(4):1240-1246. PubMed ID: 27084452
[TBL] [Abstract][Full Text] [Related]
14. Modification of p115RhoGEF Ser(330) regulates its RhoGEF activity.
Chow CR; Suzuki N; Kawamura T; Hamakubo T; Kozasa T
Cell Signal; 2013 Nov; 25(11):2085-92. PubMed ID: 23816534
[TBL] [Abstract][Full Text] [Related]
15. Gα13 mediates human cytomegalovirus-encoded chemokine receptor US28-induced cell death in melanoma.
Joshi S; Wels C; Beham-Schmid C; Fukunaga-Kalabis M; Holmen SL; Otte M; Herlyn M; Waldhoer M; Schaider H
Int J Cancer; 2015 Sep; 137(6):1503-8. PubMed ID: 25754407
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
17. G protein subunit Galpha13 binds to integrin alphaIIbbeta3 and mediates integrin "outside-in" signaling.
Gong H; Shen B; Flevaris P; Chow C; Lam SC; Voyno-Yasenetskaya TA; Kozasa T; Du X
Science; 2010 Jan; 327(5963):340-3. PubMed ID: 20075254
[TBL] [Abstract][Full Text] [Related]
18. Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway.
Wu M; Chen W; Lu Y; Zhu G; Hao L; Li YP
Nat Commun; 2017 Jan; 8():13700. PubMed ID: 28102206
[TBL] [Abstract][Full Text] [Related]
19. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.
Morin RD; Mungall K; Pleasance E; Mungall AJ; Goya R; Huff RD; Scott DW; Ding J; Roth A; Chiu R; Corbett RD; Chan FC; Mendez-Lago M; Trinh DL; Bolger-Munro M; Taylor G; Hadj Khodabakhshi A; Ben-Neriah S; Pon J; Meissner B; Woolcock B; Farnoud N; Rogic S; Lim EL; Johnson NA; Shah S; Jones S; Steidl C; Holt R; Birol I; Moore R; Connors JM; Gascoyne RD; Marra MA
Blood; 2013 Aug; 122(7):1256-65. PubMed ID: 23699601
[TBL] [Abstract][Full Text] [Related]
20. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.
Zhou X; Fang X; Jiang Y; Geng L; Li X; Li Y; Lu K; Li P; Lv X; Wang X
J Hematol Oncol; 2017 Feb; 10(1):37. PubMed ID: 28153033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
